Related references
Note: Only part of the references are listed.Gut microbial metabolites as multi-kingdom intermediates
Kimberly A. Krautkramer et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis
Stuart Astbury et al.
GUT MICROBES (2020)
Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease
Silvia Sookoian et al.
GUT (2020)
Reversal of obesity and liver steatosis in mice via inhibition of aryl hydrocarbon receptor and altered gene expression of CYP1B1, PPARα, SCD1, and osteopontin
Itzel Y. Rojas et al.
INTERNATIONAL JOURNAL OF OBESITY (2020)
Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism
Su-Ling Zeng et al.
SCIENCE ADVANCES (2020)
Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells
Elizabeth C. Rosser et al.
CELL METABOLISM (2020)
Progress and challenges in the prevention and control of nonalcoholic fatty liver disease
Jingjing Cai et al.
MEDICINAL RESEARCH REVIEWS (2019)
Functions of aryl hydrocarbon receptor (AHR) and CD38 in NAD metabolism and nonalcoholic steatohepatitis (NASH)
Karl Walter Bock
BIOCHEMICAL PHARMACOLOGY (2019)
Sulforaphane protects from myocardial ischemia-reperfusion damage through the balanced activation of Nrf2/AhR
A. Silva-Palacios et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress
Yun Ji et al.
NUTRIENTS (2019)
A tryptophan metabolite of the skin microbiota attenuates inflammation in patients with atopic dermatitis through the aryl hydrocarbon receptor
Jinlei Yu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Sulforaphane Improves Lipid Metabolism by Enhancing Mitochondrial Function and Biogenesis In Vivo and In Vitro
Peng Lei et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2019)
The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties
Teresa Vezza et al.
PHARMACOLOGICAL RESEARCH (2019)
Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications
Lijuan Zhao et al.
ENDOCRINE (2019)
Dietary inulin alleviates diverse stages of type 2 diabetes mellitus via anti-inflammation and modulating gut microbiota in db/db mice
Ke Li et al.
FOOD & FUNCTION (2019)
Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages
Smitha Krishnan et al.
CELL REPORTS (2018)
Microbial tryptophan catabolites in health and disease
Henrik M. Roager et al.
NATURE COMMUNICATIONS (2018)
Aryl Hydrocarbon Receptor Promotes IL-10 Expression in Inflammatory Macrophages Through Src-STAT3 Signaling Pathway
Junyu Zhu et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment
Rahul Shinde et al.
TRENDS IN IMMUNOLOGY (2018)
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation
David Porras et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
Albena T. Dinkova-Kostova et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2017)
Hyperhomocysteinemia Activates the Aryl Hydrocarbon Receptor/CD36 Pathway to Promote Hepatic Steatosis in Mice
Liu Yao et al.
HEPATOLOGY (2016)
Diet-microbiota interactions as moderators of human metabolism
Justin L. Sonnenburg et al.
NATURE (2016)
CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands
Bruno Lamas et al.
NATURE MEDICINE (2016)
A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet
Gabsik Yang et al.
SCIENTIFIC REPORTS (2016)
Expression of the aryl hydrocarbon receptor contributes to the establishment of intestinal microbial community structure in mice
Iain A. Murray et al.
SCIENTIFIC REPORTS (2016)
Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21
Peipei Lu et al.
HEPATOLOGY (2015)
Targeting SREBPs for treatment of the metabolic syndrome
Selma M. Soyal et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles
Troy D. Hubbard et al.
SCIENTIFIC REPORTS (2015)
Th17 and regulatory T cell balance in autoimmune and inflammatory diseases
Melissa Noack et al.
AUTOIMMUNITY REVIEWS (2014)
The Role of Diet and Nutritional Intervention for the Management of Patients with NAFLD
Francisco Barrera et al.
CLINICS IN LIVER DISEASE (2014)
Sulforaphane attenuates obesity by inhibiting adipogenesis and activating the AMPK pathway in obese mice
Kyeong-Mi Choi et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD
Claudia D. Fuchs et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Microbiome-Derived Tryptophan Metabolites and Their Aryl Hydrocarbon Receptor-Dependent Agonist and Antagonist Activities
Un-Ho Jin et al.
MOLECULAR PHARMACOLOGY (2014)
Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein
Wendy R. Russell et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
The Scap/SREBP Pathway Is Essential for Developing Diabetic Fatty Liver and Carbohydrate-Induced Hypertriglyceridemia in Animals
Young-Ah Moon et al.
CELL METABOLISM (2012)
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
Jan Petrasek et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques
Jing-Jie Tang et al.
CELL METABOLISM (2011)
Aryl Hydrocarbon Receptor-Induced Signals Up-regulate IL-22 Production and Inhibit Inflammation in the Gastrointestinal Tract
Ivan Monteleone et al.
GASTROENTEROLOGY (2011)
Type I Interferons Protect From Toll-Like Receptor 9-Associated Liver Injury and Regulate IL-1 Receptor Antagonist in Mice
Jan Petrasek et al.
GASTROENTEROLOGY (2011)
Aryl hydrocarbon receptor negatively regulates LPS-induced IL-6 production through suppression of histamine production in macrophages
Kazuya Masuda et al.
INTERNATIONAL IMMUNOLOGY (2011)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Nuclear Factor High-mobility Group Box1 Mediating the Activation of Toll-like Receptor 4 Signaling in Hepatocytes in the Early Stage of Non-alcoholic Fatty Liver Disease in Mice
L. Li et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2011)
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Kouichi Miura et al.
GASTROENTEROLOGY (2010)
Sulforaphane Suppresses Oligomerization of TLR4 in a Thiol-Dependent Manner
Hyung Sun Youn et al.
JOURNAL OF IMMUNOLOGY (2010)
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
William R. Wikoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis
Chantal A. Rivera et al.
JOURNAL OF HEPATOLOGY (2007)
Microbial community structure of ethanol type fermentation in bio-hydrogen production
Nanqi Ren et al.
ENVIRONMENTAL MICROBIOLOGY (2007)
The gut microbiota as an environmental factor that regulates fat storage
F Bäckhed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Share Paper
